Exact Mass: 265.0061
Exact Mass Matches: 265.0061
Found 193 metabolites which its exact mass value is equals to given mass value 265.0061,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Bropirimine
D007155 - Immunologic Factors > D007369 - Interferon Inducers C308 - Immunotherapeutic Agent > C2139 - Immunostimulant D000970 - Antineoplastic Agents Same as: D01666
Desacetyl-nitazoxanide
Desacetyl-nitazoxanide is a metabolite of lamivudine. Lamivudine (2,3-dideoxy-3-thiacytidine, commonly called 3TC) is a potent nucleoside analog reverse transcriptase inhibitor (nRTI). It is marketed by GlaxoSmithKline with the brand names Zeffix, Heptovir, Epivir, and Epivir-HBV. Lamivudine has been used for treatment of chronic hepatitis B at a lower dose than for treatment of HIV. It improves the seroconversion of e-antigen positive hepatitis B and also improves histology staging of the liver. (Wikipedia) D000890 - Anti-Infective Agents
(2-Carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl) hydrogen sulfate
makaluvamine N
D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D004791 - Enzyme Inhibitors
3-(1H-Imidazol-4-yl)-2-(2-thienylsulfonyl)acrylonitrile
2-amino-3,4,5,6-tetrahydro-4,6-dioxo-7-pteridinepyruvic acid
Benzenesulfonamide, 4-amino-N-(5-hydroxy-2-pyridinyl)-
2-Hydroxysaclofen
D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018756 - GABA Antagonists
Clonidine hydrochloride
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics Clonidine hydrochloride is an agonist of α2-adrenoceptor and potent antihypertensive agent.
2-OH-Saclofen
D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018756 - GABA Antagonists
4-(4-METHANESULFONYL-BENZYLIDENE)-2-METHYL-4H-OXAZOL-5-ONE
1-CYCLOPROPYL-6,7-DIFLUORO-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXYLIC ACID
ethyl 3-methyl-5-nitro-benzothiophene-2-carboxylate
6-Amino-1,7-dihydro-2H-purine-2-thione sulfate (1:1)
5(4H)-OXAZOLONE, 4-[(2-BROMOPHENYL)METHYLENE]-2-METHYL-
5(4H)-OXAZOLONE, 4-[(4-BROMOPHENYL)METHYLENE]-2-METHYL-
3-amino-2-hydroxy-[1,1-biphenyl]-3-carboxylic acid hydrochloride
2-(1,3-dioxoisoindol-2-yl)-3-methylsulfanylpropanoic acid
2-(2,3-DIHYDRO-1-BENZOFURAN-5-YL)THIAZOLE-4-CARBONYL CHLORIDE,
4-(4-Methylphenylsulfonyl)semicarbazide hydrochloride
7-BROMO-3,4,10,10A-TETRAHYDRO-2H-PYRANO[2,3-B]QUINOLINE
1-(3,4-Difluorobenzyl)-2-oxo-1,2-dihydropyridine-3-carboxylic acid
(2-amino-4,5-dimethylthiophen-3-yl)(4-chlorophenyl)methanone
6-bromo-5-methoxypyridine-2-carboximidamide,hydrochloride
3-AMINO-3-[5-(2-CHLOROPHENYL)-FURAN-2-YL]-PROPIONIC ACID
3-AMINO-3-[5-(3-CHLOROPHENYL)-FURAN-2-YL]-PROPIONIC ACID
4-(2,6-difluoro-4-methylbenzoyl)-1H-pyrrole-2-carboxylic acid
N1-(4-BROMO-1,3-DIMETHYL-1H-5-PYRAZOLYL)-2-CHLOROACETAMIDE
ethyl 6-methyl-5-nitro-1-benzothiophene-2-carboxylate
{[4-(4-METHOXYPHENYL)-4H-1,2,4-TRIAZOL-3-YL]THIO}ACETIC ACID
4-FLUORO-3-(TRIFLUOROMETHYL)-[1,1-BIPHENYL]-2-CARBONITRILE
4-FLUORO-3-(TRIFLUOROMETHYL)-[1,1-BIPHENYL]-3-CARBONITRILE
4-HYDROXYMETHYL-3-(4-NITRO-BENZYL)-2-MERCAPTO-3H-IMIDAZOLE
Avibactam
A member of the class of azabicycloalkanes that is (2S,5R)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide in which the amino hydrogen at position 6 is replaced by a sulfooxy group. Used (in the form of its sodium salt) in combination with ceftazidime pentahydrate for the treatment of complicated urinary tract infections including pyelonephritis. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D065093 - beta-Lactamase Inhibitors D004791 - Enzyme Inhibitors
3-(4-Bromophenyl)-5-methyl-1,2-oxazole-4-carbaldehyde
methyl 6-chloro-2-(4-fluorophenyl)pyridine-3-carboxylate
(2-(ISOPROPYLTHIO)-5-(TRIFLUOROMETHYL)PYRIDIN-3-YL)BORONIC ACID
5-(2-Methyl-4-nitrophenyl)furan-2-carbonyl chloride
5-bromo-6-methyl-2-pyridin-2-yl-1H-pyrimidin-4-one
5,6-DIHYDRO-4H-4-HYDROXY-6-METHYLTHIENO[2,3-B]THIOPYRAN-2-SULPHONAMIDE
(2-AMINO-5-ETHYLTHIOPHEN-3-YL)(2-CHLOROPHENYL)METHANONE
METHYL 3-(2-CHLOROPHENYL)-5-FORMYLISOXAZOLE-4-CARBOXYLATE
METHYL 3-(4-CHLOROPHENYL)-5-FORMYLISOXAZOLE-4-CARBOXYLATE
2-Methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-amine hydrochloride
ethyl 2,6-dichloro-5-nitropyrimidine-4-carboxylate
9-BROMO-2,3,4,5-TETRAHYDRO-1H-BENZO[4,5]IMIDAZO[1,2-D][1,4]DIAZEPINE
Pyridoxal phosphate hydrate
D018977 - Micronutrients > D014815 - Vitamins Pyridoxal 5'-phosphate hydrate, the active form of vitamin B6, is an essential cofactor for multiple enzymes, including aromatic l-amino acid decarboxylase that catalyzes the final stage in the production of the neurotransmitters dopamine and serotonin. Pyridoxal 5'-phosphate hydrate is the most important coenzyme variant in the process of vitamin B6 intracellular phosphorylation and is interconvertible with other variants, including pyridoxine 5′‐phosphate (PNP) and pyridoxamine 5′‐phosphate (PMP)[1][2].
4-Thiazolidinone,5-(1,3-benzodioxol-5-ylmethylene)-2-thioxo-
8-BROMO-2,3,4,5-TETRAHYDRO-1H-BENZO[4,5]IMIDAZO[1,2-D][1,4]DIAZEPINE
2-AMINO-8-PYRIDIN-3-YL-7,9-DIOXA-1-THIA-3-AZA-SPIRO[4.5]DEC-2-EN-4-ONE
8-AMINO-4-0X0-2-[1H -TETRAZOLE-5YL ) 4H-1-BENZOPYRAN HYDROCHLORIDE
2,4(1H,3H)-Pyrimidinedione,5-[bis(2-chloroethyl)amino]-6-methyl-
2-OXO-6-PYRIDIN-3-YL-4-(TRIFLUOROMETHYL)-1,2-DIHYDROPYRIDINE-3-CARBONITRILE
6-Chloro-4-nitro-3-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine
4-Chloro-3-nitro-5-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine
ETHYL 5-CYANO-3,4-DIMETHYLTHIENO[2,3-B]THIOPHENE-2-CARBOXYLATE
2-(4-chlorophenyl)sulfanylpyridine-3-carboxylic acid
ETHYL 4-(CHLOROSULFONYL)-3,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLATE
1-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]piperidine-4-carbaldehyde
Acetamide,N-[5-[(phenylmethyl)thio]-1,3,4-thiadiazol-2-yl]-
3-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]benzonitrile
4-Thiazolidinone,5-[(2-ethoxyphenyl)methylene]-2-thioxo-
2-CHLORO-N-[2-(2,4-DICHLORO-PHENYL)-ETHYL]-ACETAMIDE
3-Quinolinecarboxylicacid, 7-chloro-4-hydroxy-8-methyl-, ethyl ester
5-CHLORO-4-(4-METHYL-3-NITROPHENYL)PYRIDAZIN-3(2H)-ONE
Ethyl 5-chloro-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate
(2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate
(S)-3-(4-Chloro-benzenesulfinyl)-pyrrolidine hydrochloride
1H-Indole-3-carboxaldehyde,5-bromo-1-(1-methylethyl)-(9CI)
2-fluoro-5-[(Z)-(3-oxo-2-benzofuran-1-ylidene)methyl]benzonitrile
7-Chloro-8-fluoro-2-(trifluoromethyl)quinolin-4-ol
1-(2-BROMOPHENYL)-2-(1H-1,2,4-TRIAZOLE-1-YL)-ETHANONE
Benzoic acid,2-[(4-oxo-2-thioxo-5-thiazolidinylidene)methyl]-
6-chloro-4-hydroxy-8-methylquinoline-3-carboxylic ethyl ester
2-(4-iodo-1H-pyrazol-1-yl)propanamide(SALTDATA: FREE)
1,4,5,6-TETRAHYDRO-2-METHYL-6-OXO-4-(4-CHLOROPHENYL)-3-PYRIDINECARBOXYLIC ACID
4-ISOXAZOLECARBOXYLIC ACID, 3-(4-CHLOROPHENYL)-5-METHYL-, ETHYL ESTER
N-[5-(2-methoxyphenyl)-1,3,4-thiadiazol-2-yl]carbamic acid methyl ester
1-[4-(4-Chlorophenyl)thiazol-2-yl]-2-(propan-2-ylidene)hydrazine
2-chloro-N-(4,7-dimethyl-2-oxo-1-benzopyran-6-yl)acetamide
2-(3-Benzyl-2,4-dioxo-1,3-thiazolidin-5-yl)acetic acid
1-(3,4-Dihydroxyphenyl)-2-[(4-methyl-1,2,4-triazol-3-yl)thio]ethanone
(1E,2E)-N-[(Pentafluorophenyl)methoxy]but-2-en-1-imine
Ferric ammonium citrate
V - Various > V08 - Contrast media > V08C - Magnetic resonance imaging contrast media > V08CA - Paramagnetic contrast media D006401 - Hematologic Agents > D006397 - Hematinics > D005290 - Ferric Compounds
Amiloride hydrochloride
D049990 - Membrane Transport Modulators > D026941 - Sodium Channel Blockers > D062686 - Epithelial Sodium Channel Blockers D049990 - Membrane Transport Modulators > D026941 - Sodium Channel Blockers > D062646 - Acid Sensing Ion Channel Blockers D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics
2-(3,4-Dichlorophenyl)-2,3-dihydro-1,3-benzoxazole
(5E)-5-[(2-hydroxy-3-nitrophenyl)methylidene]-2-sulfanylideneimidazolidin-4-one
N-[3-(methylthio)-1,2,4-thiadiazol-5-yl]-2-phenylacetamide
6-chloro-2-[(1H-1,2,4-triazol-5-ylthio)methyl]imidazo[1,2-a]pyridine
N-(5-methyl-4,5-dihydrothiazol-2-yl)-3-nitrobenzamide
Sulfapyridine hydroxylamine
A pyridine having a 4-hydroxyaminobenzenesulfonamido group at the 2-position.
10-amino-9-bromo-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one
3-(4-hydroxy-2-imino-6-oxo-1,5-dihydropteridin-7-yl)-2-oxopropanoic acid
(3Z)-3-(2-amino-4,6-dioxo-5,8-dihydro-1H-pteridin-7-ylidene)-2-oxopropanoic acid
{"Ingredient_id": "HBIN009763","Ingredient_name": "(3Z)-3-(2-amino-4,6-dioxo-5,8-dihydro-1H-pteridin-7-ylidene)-2-oxopropanoic acid","Alias": "(3Z)-3-(2-amino-4,6-dioxo-5,8-dihydro-1H-pteridin-7-ylidene)-2-oxo-propanoic acid; (3Z)-3-(2-amino-4,6-diketo-5,8-dihydro-1H-pteridin-7-ylidene)-2-keto-propionic acid; 3-(2-Amino-4,5,6,8-tetrahydro-4,6-dioxopteridin-7(3H)-ylidene)-2-oxopropionic acid; 7449-03-8; EINECS 231-214-4","Ingredient_formula": "C9H7N5O5","Ingredient_Smile": "C(=C(C(=O)O)O)C1=NC2=C(C(=O)NC(=N2)N)NC1=O","Ingredient_weight": "265.18 g/mol","OB_score": "10.6551606","CAS_id": "7449/3/8","SymMap_id": "SMIT12555","TCMID_id": "NA","TCMSP_id": "MOL011684","TCM_ID_id": "NA","PubChem_id": "136217907","DrugBank_id": "NA"}
